SCHEMBL4144978

SCHEMBL4144978

O=C1[N]C(=O)C2(CCN(Cc3ccc(F)cc3)CC2)N1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
DRD2 P14416 4/20 0.45
SIGMAR1 Q99720 4/20 0.45
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRIN2B Q13224 1/20 0.45
GRIN2C Q14957 1/20 0.45
GRIN3A Q8TCU5 1/20 0.45
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HTR2B P41595 1/20 0.44
SSTR5 P35346 1/20 0.43
KCNH2 Q12809 1/20 0.43
POLB P06746 1/20 0.42
KDM4E B2RXH2 1/20 0.42
CXCR3 P49682 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4138183 0.73 SIGMAR1 (0.54) ALDH1A1DRD2SIGMAR1GRIN2DGRIN3B
SCHEMBL1507019 0.71 HRH3 (0.52) ALDH1A1DRD2SIGMAR1GRIN2DGRIN3B
SCHEMBL4143507 0.71 KDM4E (0.34) ALDH1A1DRD2SIGMAR1HTR2APOLB
SCHEMBL14774848 0.70 DRD2 (0.50) ALDH1A1DRD2SIGMAR1GRIN2DGRIN3B
SCHEMBL8117468 0.70 MAPT (0.67) SIGMAR1KDM4E
SCHEMBL4147779 0.70 CYP2D6 (0.40) ALDH1A1
SCHEMBL2794745 0.68 TACR1 (0.55) ALDH1A1DRD2SIGMAR1HTR2AHTR2C
SCHEMBL11888852 0.67 ALDH1A1 (0.56) ALDH1A1MEN1KMT2A
SCHEMBL26962967 0.67 HRH3 (0.67) ALDH1A1KDM4E
SCHEMBL5319459 0.67 HRH3 (0.74) ALDH1A1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054467-A1 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases BETSCHART CLAUDIA 2009-02-26 US disclosed
US-7452886-B2 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases NOVARTIS AG (CH) 2008-11-18 US disclosed
EP-1423391-B8 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2007-12-12 EP disclosed
EP-1423391-B1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2006-05-17 EP disclosed
US-20050054851-A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases NOVARTIS AG (CH) 2005-03-10 US disclosed
EP-1423391-A1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES Novartis AG (CH) 2004-06-02 EP disclosed
WO-2003020721-A1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2003-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054851-A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases CTSK, CTSS, CTSZ ALDH1A1 2931/4885DRD2 4870/4885SIGMAR1 4770/4885
US-20090054467-A1 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases CTSK, CTSS, CTSZ ALDH1A1 2931/4885DRD2 4870/4885SIGMAR1 4770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.